Astrocyte-specific expression of human T-cell lymphotropic virus type 1 (HTLV-1) Tax: Induction of tumor necrosis factor alpha and susceptibility to lysis by CD8+ HTLV-1-specific cytotoxic T cells

Journal of Virology

Volumn 71, Issue 12, 1997, Pages 9143-9149

  Méndez, Eduardo ^a   Kawanishi, Taketo ^a   Clemens, Karen ^b   Siomi, Haruhiko ^c   Soldan, Samantha S ^a   Calabresi, Peter ^a   Brady, John ^b   Jacobson, Steven ^a,d  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; TAX PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; PRIORITY JOURNAL; VIRUS CELL INTERACTION;

EID: 1842296910     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.12.9143-9149.1997     Document Type: Article

References (54)

1. Akizuki, S., S. Yoshida, M. Setoguchi, Y. Higuchi, S. Yamamoto, O. Nakazato, and T. Okajima. 1989. The neuropathology of human T cell lympho-tropic virus type I-associated myelopathy, p. 253-260. In G. C. Roman, J. C. Vernant, and M. Osame (ed.), HTLV-1 and the nervous system. Alan R. Liss, New York, N.Y.
2. Brosnan, C. F., K. Selmaj, and C. S. Raine. 1988. Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J. Neuroimmunol. 18:87-94.
3. Daenke, S., S. Nightingale, J. K. Cruickshank, and C. R. M. Bangham. 1990. Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurologic from leukemic isolates. J. Virol. 64:1278-1282.
4. Elovaara, I., S. Koenig, A. Brewah, and S. Jacobson. 1993. High HTLV-I specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-I associated neurologic disease. J. Exp. Med. 177:1567-1573.
5. Fox, R. J., M. C. Levin, and S. Jacobson. 1996. Tumor necrosis factor alpha expression in the spinal cord of human T-cell lymphotropic virus type I associated myelopathy/tropical spastic paraparesis patients. J. Neurovirol. 2:323-329.
6. Gessain, A., J. C. Vernant, L. Maurs, A. Calender, and G. de The. 1985. Antibodies to human T-lymphotropic virus I in patients with tropical spastic paraparesis. Lancet ii:407-410.
7. Gessain, A., F. Saal, V. Morozov, J. Lasneret, D. Vilette, O. Gout, R. Emanoli-Ravier, F. Sigaux, G. de The, and J. Peries. 1989. High human T cell lymphotropic type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells from Fench West Indian patients with tropical spastic paraparesis. Int. J. Cancer 43:327-333.
8. Ginsberg, D., G. Vairo, T. Chittenden, Z. Xiao, G. Xu, K. L. Wydner, J. A. Decaprio, B. Lawrence, and D. M. Livingston. 1994. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev. 8:2665-2679.
9. Hoffman, P. M., S. Dhib-Jalbut, J. A. Mikovits, D. S. Robbins, A. L. Wolf, G. K. Bergey, N. C. Lohrey, O. S. Weislow, and F. W. Ruscetti. 1992. Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cultures. Proc. Natl. Acad. Sci. USA 89:11784-11788.
10. Höllberg, P., and D. A. Hafler. 1993. Pathogenesis of disease induced by human lymphotropic virus type I infection. N. Engl. J. Med. 328:1173-1182.
11. Itoyamai Y., S. Minato, J. Kira, I. Goto, H. Sato, K. Okochi, and N. Yamamoto. 1988. Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I associated myelopathy. Neurology 38:1302-1307.
12. Jacobson, S., A. Gupta, D. Mattson, E. Mingioli, and D. E. McFarlin. 1990. Immunologic studies in tropical spastic paraparesis (TSP). Ann. Neurol. 27:149-156.
13. Jacobson, S., D. E. McFarlin, S. Robinson, R. Voskuhl, R. Martin, A. Brewah, A. J. Newell, and S. Koenig. 1992. HTLV-I-specific cytotoxic T lymphocytes in the cerebrospinal fluid of patients with HTLV-I-associated neurologic disease. Ann. Neurol. 32:L651-L657.
14. 8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348:245-248.
15. Jacobson, S. 1996. Role of cellular immune responses in the pathogenesis of HTLV-I-associated neurologic disease, p. 141-166. In P. Hollsberg and D. A. Hafler (ed.), Human T-cell lymphotropic virus type I. John Wiley & Sons Ltd., Chichester, England.
16. 8+ cytotoxic T cells directed against HTLV-I infected cells. Int. Immunol. 3:761-767.
17. Khabbaz, R. F., W. W. Darrow, M. Trudie, T. M. Hartley, J. Witte, J. B. Cohen, J. French, P. S. Gill, J. Potterat, R. K. Sikes, R. Reich, J. E. Kaplan, and M. D. Lairmore. 1990. Seroprevalence and risk factors for HTLV-I/II infection among female prostitutes in the United States. JAMA 263:60-64.
18. Kira, J., Y. Koyanagi, T. Yamada, Y. Itoyama, I. Goto, N. Yamamoto, H. Sasaki, and Y. Sasaki. 1991. Increased HTLV-I proviral DNA in HTLV-I associated myelopathy: a quantitative polymerase chain reaction study. Ann. Neurol. 29:194-201.
19. Kitajima, I., M. Osame, S. Izumo, and A. Igata. 1988. Immunological studies of HTLV-I associated myelopathy. Autoimmunity 1:125-131.
20. Kitze, B., M. Puccioni-Sohler, J. Schaffner, P. Rieckmann, T. Weber, K. Felgenhauer, and W. Bodemer. 1995. Specificity of intrathecal IgG synthesis for HTLV-I core and envelope proteins in HAM/TSP. Acta Neurol. Scand. 92:213-217.
21. Koenig, S., R. Woods, Y. A. Brewah, A. J. Newell, G. M. Jones, E. Boone, J. W. Adelsberger, M. W. Baseler, S. M. Robinson, and S. Jacobson. 1993. Characterization of major histocompatibility complex (MHC) class I restricted cytotoxic T cell (CTL) responses to Tax in HTLV-I infected patients with neurologic disease. J. Immunol. 151:3874-3883.
22. Kubota, R., F. Umehara, S. Izumo, S. Ijichi, K. Matsumuro, S. Yashiki, T. Fujiyoshi, S. Sonoda, and M. Osame. 1994. HTLV-I proviral DNA correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I associated myelopathy. J. Neuroimmunol. 53:23-29.
23. Kuroda, Y., M. Matsui, H. Takashima, and K. Kurohara. 1993. Granulocyte-macrophage colony-stimulating factor and interleukin-1 in cerebrospinal fluid, but not in serum, of HTLV-I-associated myelopathy. J. Neuroimmunol. 45:133-136.
24. Kuroda, Y., and M. Matsui. 1993. Cerebrospinal fluid interferon-gamma is increased in HTLV-I-associated myelopathy. J. Neuroimmunol. 42:223-226.
25. Lahdevirta, J., C. P. Maury, A. Teppo, and H. Repo. 1988. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. J. Med. 85:289-291.
26. Langton, B. C., M. Sliwkowski, K. V. Tran, S. Knapp, E. Kaitelman, C. Smith, S. Wallingford, H.-L. Liu, J. S. Ralston, J. Brandis, and S. Coates. 1988. Development and characterization of monoclonal antibodies to the HTLV-I Tax (p40X) protein. Med. Virol. 8:295.
27. Lehky, T. J., E. P. Cowan, L. A. Lampson, and S. Jacobson. 1994. Induction of HLA class I and class II expression in human T-lymphotropic virus type I-infected neuroblastoma cells. J. Virol. 68:1854-1863.
28. Lehky, T. J., C. H. Fox, S. Koenig, M. C. Levin, N. Flerlage, S. Izumo, E. Sato, C. S. Raine, M. Osame, and S. Jacobson. 1995. Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann. Neurol. 47:167-175.
29. Lehky, T. J., and S. Jacobson. 1995. Induction of HLA class II in HTLV-I infected neuronal cell lines. J. Neurovirol. 1:145-156.
30. Levin, M. C., T. J. Lehky, A. N. Flerlage, D. Katz, D. W. Kingma, E. S. Jaffe, J. D. Heiss, N. Patronas, H. F. McFarland, and S. Jacobson. 1997. Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease. N. Engl. J. Med. 336:839-845.
31. Link, H., M. Cruz, A. Gessain, O. Gout, G. de The, and S. Kam-Hansen. 1989. Chronic progressive myelopathy associated with HTLV-I: oligoclonal : and anti-HTLV-I IgG antibodies in the cerebrospinal fluid and serum. Neurology 39:1566-1572.
32. Mattson, D. H., D. E. McFarlin, C. Mora, and V. Zaninovic. 1987. Central-nervous-system lesions detected by resonance imaging in an HTLV-I antibody positive symptomless individual. Lancet ii:49.
33. McFarlin, D. E., and W. A. Blattner. 1991. Non-AIDS retroviral infections in humans. Annu. Rev. Med. 42:97-105.
34. Mintz, M., R. Rapaport, J. M. Oleske, E. M. Connor, M. R. Koenigsberger, T. Denny, and L. G. Epstein. 1989. Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome. Am. J. Dis. Child. 143:771-774.
35. Morimoto, C., T. Matsuyama, C. Oshige, H. Tanaka, T. Hercend, E. L. Reinherz, and S. F. Schlossman. 1985. Functional and phenotypic studies of Japanese adult T cell leukemia cells. J. Clin. Invest. 75:836-843.
36. Nakagawa, M., S. Izumo, S. Ijichi, et al. 1995. HTLV-I associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J. Neurovirol. 1:50-61.
37. Nishimoto, N., K. Yoshizaki, N. Eiraku, K. Machigashira, H. Tagoh, A. Ogata, T. Kuritani, M. Osame, and T. Kishimoto. 1990. Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy/tropical spastic paraparesis. J. Neurolog. Sci. 97:183-193.
38. Nishimura, M., D. E. McFarlin, and S. Jacobson. 1993. Sequence comparisons of HTLV-I from HAM/TSP patients and their spouses. Neurology 43:2621-2624.
39. Ohbo, K., K. Sugamura, T. Sekizawa, and K. Kogure. 1991. Interleukin-6 in cerebrospinal fluid of HTLV-I-associated myelopathy. Neurology 41:594-595.
40. Osame, M., K. Usuku, S. Izumo, N. Ijichi, H. Amitani, A. Igata, M. Matsumoto, and M. Tara. 1986. HTLV-I associated myelopathy: a new clinical entity. Lancet i:1031-1032.
41. Parker, C. E., S. Daenke, S. Nightingale, and C. R. Bangham. 1992. Activated, HTLV-I specific cytotoxic T lymphocytes are found in healthy sero-positives as well as patients with tropical spastic paraparesis. Virology 188: 628-636.
42. Paul, W. E. (ed.). 1993. Fundamental immunology, 3rd ed., p. 807-812. Raven Press, New York, N.Y.
43. Poeisz, B. J., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo. 1980. Detection and isolation of typo C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T cell lymphoma. Proc. Natl. Acad. Sci. USA 77:7415-7419.
44. Richardson, J. H., A. J. Edwards, J. K. Cruickshank, P. Rudge, and A. G. Dalgleish. 1990. In vivo cellular tropism of human T-cell leukemia virus type I. J. Virol. 64:5682-5687.
45. Sabe, H., A. Tanaka, H. Siomi, S. Koyasu, S. Yonehara, I. Yahara, Y. Tagaya, K. Sugie, K. Teshigawara, J. Yodoi, and M. Hatanaka. 1988. Differential effects on expression of IL-2 receptors (p55 and p70) by the HTLV-I pX DNA. Int. J. Cancer 41:880-885.
46. Selmaj, K. W., and C. S. Raine. 1988. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:339-346.
47. Toggas, S. M., E. Masliah, E. M. Rockenstein, G. F. Rail, C. R. Abraham, and L. Mucke. 1994. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367:188-193.
48. Tschachler, E., M. Robert-Guroff, R. C. Gallo, and M. S. Reitz, Jr. 1989. Human T-lymphotropic virus I-infected T cells constitutively express lymphotoxin in vitro. Blood 73:194-201.
49. Uchiyama, T., J. Yodoi, K. Sagawa, K. Takatsuki, and H. Uchino. 1977. Adult T cell leukemia: clinical and hematologic features of 16 cases. Blood 50:481-492.
50. Usuku, K., S. Sonada, M. Osame, S. Yashiki, K. Takahashi, M. Matsumoto, T. Sawada, K. Tsuji, M. Tara, and A. Igata. 1988. HLA-haplotype-linked high immune responsiveness against HTLV-I in HTLV-I associated myelopathy: comparison with adult T cell leukemia/lymphoma. Ann. Neurol. 23: S143-S150.
51. Utz, U., S. Koenig, J. E. Coligan, and W. E. Biddison. 1992. Presentation of 3 different viral peptides, HTLV-I tax, HCMV gB, and influenza virus M1 is determined by common structural features of the HLA A2.1 molecule. J. Immunol. 149:1896-1904.
52. Waage, A., A. Halstensen, R. Shalaby, P. Brandtaeg, and T. Espevik. 1989. Local production of tumor necrosis factor a, interleukin 1, and interleukin 6 in meningoccocal meningitis. Relation to the inflammatory response. J. Exp. Med. 170:1859-1867.
53. Wu, E., D. W. Dickson, S. Jacobson, and C. S. Raine. 1993. Neuroaxonal dystrophy in HTLV-I associated myelopathy/tropical spastic paraparesis: neuropathologic and neuroimmunologic correlations. Acta Neuropathol. 86: 224-235.
54. Yoshida, M., M. Seiki, K. Yamaguchi, and K. Takasuki. 1984. Monoclonal integration of human T cell leukemia provirus in all primary tumors of adult T cell leukemia suggest a causative role of human T cell leukemia virus in the disease. Proc. Natl. Acad. Sci. USA 81:2534-2537.